Title: Founder and CEO Workplace: Prelude Therapeutics Alma Maters: Andhra Pradesh Agricultural University, University of Florida Boards: Acellus Health, University of Delaware’s Research Foundation and Biopharmaceutical Innovation Q&A: What’s something […]
Prelude Therapeutics cut the ribbon on its new headquarters on Friday morning, signaling the next chapter in the company's growth.
Prelude Therapeutics, a cancer drug development firm, closed a $25 million share sale Wednesday that will help extend its funding runway.
WILMINGTON – Prelude Therapeutics is one of Delaware’s burgeoning life science success stories, and it recently announced a new milestone in signing its first partnership agreement with a major Canadian […]
The first Delaware DNA conference hosted by the Delaware BioScience Association drew about 350 people to network and listen to panels.
© 2024 Delaware Business Times